Company Overview

Unicharm Corporation engages in the manufacture and sale of baby and childcare, feminine care, health care, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers and baby wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; and feminine care products comprise napkins, tampons, panty liners, sanitary short, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand; and masks under the Unicharm brands. It also provides home care products, including cleaning sheets under the Wave brand; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, Aiken Genki, and Neko Genki brands. Further, it is involved in the manufacture and sale of industrial materials, food-packaging materials, etc. The company was incorporated in 1941 and is headquartered in Tokyo, Japan.

  • Name

    Unicharm Corporation

  • CEO

    Mr. Takahisa Takahara

  • Website

    www.unicharm.co.jp

  • Sector

    Household Products

  • Year Founded

    1941

Profile

  • Market Cap

    ¥2,981.23B

  • EV

    ¥2,737.55B

  • Shares Out

    586.4M

  • Revenue

    ¥975.58B

  • Employees

    16,223

Margins

  • Gross

    39.01%

  • EBITDA

    19.89%

  • Operating

    15.24%

  • Pre-Tax

    14.83%

  • Net

    9.33%

  • FCF

    11.22%

Returns (5Yr Avg)

  • ROA

    6.74%

  • ROTA

    11.92%

  • ROE

    10.34%

  • ROCE

    16.29%

  • ROIC

    13.45%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    ¥5,819

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    ¥229.35B

  • Net Debt

    -¥202.23B

  • Debt/Equity

    0.03

  • EBIT/Interest

    24.26

Growth (CAGR)

  • Rev 3Yr

    9.26%

  • Rev 5Yr

    6.71%

  • Rev 10Yr

  • Dil EPS 3Yr

    8.17%

  • Dil EPS 5Yr

    10.4%

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    6.16%

  • EBITDA Fwd 2Yr

    9.16%

  • EPS Fwd 2Yr

    10.39%

  • EPS LT Growth Est

    11.5%

Dividends

  • Yield

  • Payout

    40.18%

  • DPS

    ¥62

  • DPS Growth 3Yr

    22.17%

  • DPS Growth 5Yr

    18.98%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    8.86%

TSE:8113